Buprenorphine for Probationers and Parolees: Bridging the Gap Into Treatment
Status:
Active, not recruiting
Trial end date:
2023-04-30
Target enrollment:
Participant gender:
Summary
This five-year study will evaluate the effectiveness of the administration of buprenorphine
bridge treatment (BBT) to probationers and parolees compared to treatment as usual (TAU),
which consists of referral to a community buprenorphine treatment program.
Phase:
Phase 3
Details
Lead Sponsor:
Friends Research Institute, Inc.
Treatments:
Buprenorphine Buprenorphine, Naloxone Drug Combination Naloxone